The trademark application RGC was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 1, 2022, and it was registered by office on August 8, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).